Merck KGaA to buy Silence Therapeutics for $20 per ADS in cash
Germany's Merck KGaA agrees to acquire London-based Silence Therapeutics in an all-cash deal with equity value near $1.3 billion, Barron's reports.
1 source · Barrons.com
energy, macro and geopolitical news for traders, with market context and links to the original sources.
stories appear as soon as they are checked. for bots and dashboards — the api connect the api →
2 stories
Germany's Merck KGaA agrees to acquire London-based Silence Therapeutics in an all-cash deal with equity value near $1.3 billion, Barron's reports.
1 source · Barrons.com
Reuters: US index futures climbed as AI-linked stocks recovered from a selloff, while Brent and Treasury yields fell after a Russia sanctions decision.
1 source · Reuters